
The ACMA MedicalAffairsLeadershipSummit returns on April 30, 2026, following a sold-out event in 2025 that left Medical Affairs & MSL Industry Leaders wanting more.
This one-day, in-person event exclusively brings together exclusive top executives and visionary Medical Affairs leaders across the Pharmaceutical and Life Sciences Industries.
Get real-world insights into challenges and innovations shaping our industry and strategies that truly make a measurable impact.
Build powerful peer relationships with executives from leading companies in an environment designed for connection and collaboration.
An event specifically curated and designed for maximum value with actionable outcomes.
"Absolutely the most relevant, high-impact Medical Affairs event I've attended all year."
"The speaker lineup was world-class. Every session delivered value."
"This wasn't just a conference, it was a leadership experience."
Robert Laudadio, Director of Strategic Marketing & Partnerships | Tel: 201.819.6145 | Email: robert.laudadio@acmainfo.org

Come away with real-world insights and strategies that will make an impact in your partnerships. Each session is comprised of 20 minute didactic presentation and 30 minute interactive exchange
Attendees can share their distinct case examples and engage experts for precise, case-based recommendations.
Participants get to connect one-on-one with speakers to address their own case situations and obtain targeted solutions.
Physicians are not overwhelmed by access. They are overwhelmed by irrelevance. As clinical complexity increases and digital noise grows, doctors are becoming far more selective about when, how, and with whom they engage from industry.
This session shows how Medical Affairs leaders can shift from broad outreach to precision engagement through right channeling. Using physician preference data, real-world behavior, and AI-powered decisioning, teams can predict when physicians want to self-serve medical content and when they are ready for a meaningful interaction with an MSL or other medical partner.
Participants to discuss individual cases with panelists and receive specific, personalized feedback.
With the volume of scientific data accelerating, traditional education models can no longer keep pace with evolving HCP needs. A persistent “evidence‑to‑practice” lag limits patient impact. This session introduces agentic AI, multi-agent systems (MAS) and systems of agent networks (SAN) that streamline evidence assessment, content creation, and omnichannel delivery to close that lag between discovery and clinical adoption. Through a demo of Cognizant’s NeuroSAN, attendees will see how AI-driven tools can personalize HCP learning needs while adhering to standards of medical affairs (ACMA, IACET, ANSI, ACCME, ACPE)
Participants can pose their case-specific questions to the speakers for focused, individualized guidance.
Attendees can share their distinct case examples and engage experts for precise, case-based recommendations.
Participants get to connect one-on-one with speakers to address their own case situations and obtain targeted solutions.
Physicians are not overwhelmed by access. They are overwhelmed by irrelevance. As clinical complexity increases and digital noise grows, doctors are becoming far more selective about when, how, and with whom they engage from industry.
This session shows how Medical Affairs leaders can shift from broad outreach to precision engagement through right channeling. Using physician preference data, real-world behavior, and AI-powered decisioning, teams can predict when physicians want to self-serve medical content and when they are ready for a meaningful interaction with an MSL or other medical partner.
Participants to discuss individual cases with panelists and receive specific, personalized feedback.
With the volume of scientific data accelerating, traditional education models can no longer keep pace with evolving HCP needs. A persistent “evidence‑to‑practice” lag limits patient impact. This session introduces agentic AI, multi-agent systems (MAS) and systems of agent networks (SAN) that streamline evidence assessment, content creation, and omnichannel delivery to close that lag between discovery and clinical adoption. Through a demo of Cognizant’s NeuroSAN, attendees will see how AI-driven tools can personalize HCP learning needs while adhering to standards of medical affairs (ACMA, IACET, ANSI, ACCME, ACPE)
Participants can pose their case-specific questions to the speakers for focused, individualized guidance.
Robert Laudadio, Director of Strategic Marketing & Partnerships | Tel: 201.819.6145 | Email: robert.laudadio@acmainfo.org
The ACMA Medical Affairs Leadership Summit 2026 offers an exclusive sponsorship opportunity limited to just six industry partners. Unlike traditional events, sponsors will not be separated in a distant exhibit hall, instead, they'll be embedded directly into the main event space, side-by-side with attendees and speakers for the full day.
This is more than visibility- it's strategic immersion. Sponsors will walk away not just with leads, but with lasting connections, competitive intelligence, and direct access to the people shaping industry standards.
Spots are extremely limited. Secure your presence at the forefront of Medical Affairs innovation.
Contact: Robert Laudadio, Director of Strategic Marketing & Partnerships
Telephone: 201 819 6145
Email: robert.laudadio@acmainfo.org
